Is the risk of venous thromboembolic disease truly an absolute contraindication for menopause hormone therapy?
Česká gynekologie · 22.10.2026 · 91 (5) · 408-416
DOI: 10.48095/cccg2026408 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Česká gynekologie, online erschienen am 23.10.2026. Verfasst von Tomáš Fait und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Venous Thromboembolism, Estrogen Replacement Therapy.
Abstract (Originalsprache)
Oral menopause hormone therapy (MHT) is associated with a two- to four-fold increased risk of venous thromboembolism (VTE). According to the majority of studies, the increased risk of venous thromboembolic disease does not apply to transdermal administration. Transdermal MHT is considered safe even in women at a high risk of thromboembolic disease (such as those with overweight, obesity, thrombophilic conditions, recent surgery, immobilization, varicose veins, malignancy, or smoking). Acute VTE represents an absolute contraindication to both oral and transdermal administration of MHT. A personal history of VTE is an absolute contraindication to oral MHT, but only a relative contraindication for the transdermal route of MHT. Menopause hormone therapy must be personalized for each woman. Key words: menopause hormone therapy – transdermal application – venous thromboembolic disease – thrombophilic mutation – overweight – chronic estrogen deficiency
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
ORCID-Profile: Tomáš Fait, S Šimková, V Dvořáková
Zitieren
APA
Fait, T., Šimková, S., & Dvořáková, V. (2026). Is the risk of venous thromboembolic disease truly an absolute contraindication for menopause hormone therapy?. Česká gynekologie, 91(5), 408-416. https://doi.org/10.48095/cccg2026408
Vancouver
Fait T, Šimková S, Dvořáková V. Is the risk of venous thromboembolic disease truly an absolute contraindication for menopause hormone therapy?. Česká gynekologie. 2026;91(5):408-416. doi:10.48095/cccg2026408
BibTeX
@article{Fait2026,
author = {Fait, Tomáš and Šimková, S and Dvořáková, V},
title = {Is the risk of venous thromboembolic disease truly an absolute contraindication for menopause hormone therapy?},
journal = {Česká gynekologie},
year = {2026},
volume = {91},
number = {5},
pages = {408--416},
doi = {10.48095/cccg2026408}
}
EUVIMED